Papers: 10.1371/journal.pone.0226754

https://doi.org/10.1371/journal.pone.0226754

Cost-utility analysis of de-escalating biological disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis

Cited by: 7
Author(s): Benjamin Birkner, Jürgen Rech, Tom Stargardt
Published: almost 7 years ago

Software Mentions 1